- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Safety Data Sheets
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Diversity, Equity, and Inclusion Everyone has something to offer
- EHS Governance
- Environmental Sustainability Our responsiblity to the environment
- Global Impact Meeting urgent needs worldwide
- Health & Safety
- Human Rights Furthering dignity and worth
- Intellectual Property The benefits of fair competition
- Patient Advocacy & Engagement Putting Patients First
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- History
- Careers
- Partners
- People
The Antigen Podcast Episode 8: What's Next?
In this final episode, we’ll examine the potential of vaccines to help fight emerging global health threats, like anti-microbial resistance & new diseases like COVID-19, as well as what the medical community—and the rest of the world—is doing about it. We'll also wrap up the series by understanding how vaccines may help us lead healthier lives, from the moment we’re born to older age.
Host Yasmeen Agosti speaks to Anna Mouser of Wellcome Trust, Prof. David Salisbury of Chatham House, Prof. Kevin Outterson of Boston University’s CARB-X Foundation, Jane Barratt of IFA, and Dr. Carol J. Baker of University of Texas Health Science Center.
See the full transcript for Episode 8 here
Episode Guests
- Dr. Carol J. Baker, University of Texas Health Science Center
- Jane Barratt, IFA
- Anna Mouser, Wellcome Trust
- Kevin Outterson, Boston University’s CARB-X Foundation
- David Salisbury, Chatham House
Episode References
- CARB-X
- Centers for Disease Control
- World Health Organization
Season 1 Host
Season 1 of The Antigen is hosted by Yasmeen Agosti, MD FAAP. Yasmeen is a pediatrician and a Global Medical Lead, Viral Vaccines at Pfizer. She is a Ph.D. candidate in Clinical Microbiology and Infectious Diseases at the University of Witwatersrand. Yasmeen trained as a general pediatrician in Philadelphia and, later, conducted clinical research on respiratory syncytial virus in South Africa as part of her doctoral studies. She joined Pfizer in 2017. Learn more about her background and current work at Pfizer.
*Guests have not been compensated for their participation on this podcast.